Common Soil Bacterium Emerges as Stealth Threat in Preterm Infant Wards

In the sterile environment of a neonatal intensive care unit, where the smallest and most fragile patients fight for every day of life, an unexpected adversary has been quietly making itself known. Bacillus cereus, a bacterium better known to the public for causing food poisoning from reheated rice, has emerged as an uncommon but potentially devastating cause of bloodstream infection in hospitalized preterm infants. A new retrospective study from Quanzhou Maternal and Child Health Hospital in Fujian Province, China, now offers one of the largest single-center portraits of this infection to date, documenting nineteen cases of Bacillus cereus sepsis among preterm infants and, crucially, drawing attention to a neurological complication that the authors believe has been dangerously underrecognized: brain abscess.

The study, published in BMC Infectious Diseases, analyzed clinical records from infants admitted to the hospital’s neonatal intensive care unit between May 2023 and February 2025. All of the patients were preterm, and the median age at which sepsis first appeared was just sixteen days, though the range stretched remarkably wide, from seven days to 223 days after birth. That timing matters. Late-onset sepsis, meaning infection that develops after the first seventy-two hours of life, is a leading cause of illness and death in preterm infants, and the usual suspects are well-known organisms such as coagulase-negative staphylococci. Bacillus cereus rarely tops the list of clinical suspicions, and that is precisely the problem the researchers set out to illuminate.

The clinical picture that emerged from the nineteen cases was strikingly non-specific, which helps explain why the organism is so easy to overlook. Every single infant, one hundred percent of the cohort, presented with poor responsiveness, a vague sign that overlaps with countless other conditions in fragile newborns. Fever was present in fourteen patients, or 73.9 percent, and apnea, the temporary cessation of breathing, occurred in twelve infants, accounting for 63.2 percent. None of these findings would immediately point a clinician toward Bacillus cereus. In fact, the study’s authors note that positive blood cultures for this organism are frequently dismissed as contamination, since Bacillus species are common environmental organisms that can inadvertently seed a culture bottle during sampling. Distinguishing true invasive infection from a stray contaminant requires clinical judgment, and the stakes of getting that call wrong are now considerably clearer.

One of the most consequential findings of the study concerned breathing. Among the sixteen infants who had not been receiving invasive mechanical ventilation before the onset of sepsis, ten, or 62.5 percent, required escalation to a higher level of respiratory support once the infection took hold. The researchers report this figure with a 95 percent confidence interval of 35.4 percent to 84.8 percent, a wide range that reflects the modest sample size but still signals a consistent pattern. In practical terms, a sudden deterioration in respiratory status in a preterm infant, manifesting as new or worsening apnea and increased oxygen requirements, may be one of the earliest and most reliable signals that sepsis is developing. For neonatal clinicians, the message is that a step up in respiratory support should trigger a careful search for infection, including blood cultures, rather than being attributed to the infant’s underlying prematurity alone.

The microbiology added its own sobering lessons. Every strain isolated in the cohort was resistant to penicillin and ampicillin, the beta-lactam antibiotics that form the backbone of empiric therapy for many neonatal infections. This resistance is a hallmark of Bacillus cereus, which produces beta-lactamase enzymes that dismantle penicillin-class drugs. The good news is that all strains remained susceptible to meropenem, vancomycin, and linezolid, giving clinicians effective options once the organism is identified. But the resistance pattern underscores a diagnostic trap: if Bacillus cereus is not considered and the infant is treated with ampicillin alone, the infection may continue to progress even as treatment appears to be under way. Timely identification of the organism and rational adjustment of the antimicrobial regimen are therefore not optional refinements but essential steps in managing these patients.

The most alarming dimension of the study concerns the central nervous system. Two of the nineteen infants, or 10.5 percent, developed purulent meningitis, the bacterial infection of the membranes surrounding the brain, and one of those cases progressed to a brain abscess, a localized collection of pus within brain tissue itself. The researchers provided a detailed account of this abscess case and then cast a wider net, searching the published literature for other reported cases of neonatal Bacillus cereus brain abscess. Combining their own patient with the literature yielded fifteen cases in total. Among those fifteen infants, five deaths were reported, a mortality rate of 33.3 percent. And the toll did not end with survival: some of the children who lived were left with neurological sequelae, lasting damage to brain function that can shape development for a lifetime.

The outcome of the Quanzhou abscess case illustrates both the gravity of the complication and the possibility of rescue through aggressive intervention. The infant survived after undergoing surgical drainage of the abscess combined with long-term antimicrobial therapy, a regimen that must be sustained for weeks to eradicate bacteria sequestered within an abscess cavity, where antibiotic penetration is poor and the blood-brain barrier complicates drug delivery. Yet survival came with a caveat. At twenty months of age, the child exhibited mild neuromotor developmental delay, a reminder that even successfully treated central nervous system infection in a preterm infant can leave subtle but meaningful traces on the developing brain. The developing nervous system of a premature infant is uniquely vulnerable, and inflammatory injury during critical windows of brain maturation can disrupt processes that unfold over months and years.

Overall mortality in the cohort was 5.3 percent, meaning one of the nineteen infants died, with a 95 percent confidence interval of 0.1 percent to 26.0 percent. That figure, while far lower than the mortality seen in the brain abscess literature, still represents a death toll from an organism that many clinicians would regard as a nuisance contaminant. The authors argue that their findings justify a more proactive diagnostic pathway. In their view, any preterm infant with a positive blood culture for Bacillus cereus should undergo lumbar puncture to examine the cerebrospinal fluid and cranial imaging as soon as possible, rather than waiting for neurological signs to appear. By the time seizures, bulging fontanelles, or other overt signs of central nervous system involvement emerge, an abscess may already be forming. Serial neuroimaging and long-term neurodevelopmental follow-up round out the recommended approach, ensuring that survivors are monitored for delays that may only become apparent as they grow.

Where does the bacterium come from in the first place? The study points to potential sources that are uncomfortably close to the infant’s bedside: contaminated environmental surfaces, medical equipment, and nutritional products, including breast milk and formula. Bacillus cereus is a spore-forming organism, and its spores are notoriously resistant to heat, drying, and disinfectants, allowing it to persist on surfaces and in equipment long after cleaning. This resilience is what makes the bacterium such a formidable opportunist in hospital settings. The authors emphasize that prevention rests on disciplined fundamentals: strict hand hygiene among staff and caregivers, regular and thorough disinfection of the environment and medical devices, and careful handling of breast milk and formula to prevent bacterial growth. These measures are neither glamorous nor technologically novel, but they target the routes by which spores travel from the environment into the bloodstream of an infant whose immune defenses are still under construction.

The significance of this study lies less in any single statistic than in the cumulative picture it paints. Bacillus cereus sepsis in preterm infants is rare enough that most evidence has previously been limited to isolated case reports or small series, leaving clinicians without a clear sense of the typical presentation, the likely course, or the full range of complications. By assembling nineteen cases from a single center and pairing them with a systematic review of the brain abscess literature, the Quanzhou team has transformed a scattered collection of anecdotes into a coherent clinical profile: a non-specific onset marked by poor responsiveness, fever, apnea, and escalating respiratory support; universal beta-lactam resistance demanding prompt antimicrobial adjustment; and a real, quantifiable risk of meningitis and brain abscess with lasting developmental consequences. For the neonatologists and infection-control teams who staff the world’s intensive care nurseries, the study is a call to take this soil-dwelling organism seriously, to investigate positive cultures rather than dismissing them, and to look beyond the bloodstream toward the brain before it is too late.

Subject of Research: Invasive Bacillus cereus sepsis and neurological complications in hospitalized preterm infants

Article Title: Invasive Bacillus cereus infection in hospitalized preterm infants: clinical characteristics, outcomes, and neurological complications from a single-center retrospective case series

Article References: Invasive Bacillus cereus infection in hospitalized preterm infants: clinical characteristics, outcomes, and neurological complications from a single-center retrospective case series. (n.d.). https://doi.org/10.1186/s12879-026-14504-y

Image Credits: AI Generated

DOI: 10.1186/s12879-026-14504-y

Keywords: Bacillus cereus, preterm infants, neonatal sepsis, brain abscess, meningitis, neonatal intensive care, antimicrobial resistance, meropenem, vancomycin, neurodevelopmental delay, healthcare-associated infection, infection control